Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(21 sites)

United States

Lynn Institute of the Ozarks, Little Rock, Arkansas

Family First Medical Research Center, Hialeah Gardens, Florida

Alliance for Multispecialty Research (AMR Clinical) - Wichita East, Lakeland, Florida

CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis), Lakeland, Florida

GTL Medical & Research Group, Miami, Florida

Florida Institute for Clinical Research LLC, Orlando, Florida

AMR Clinical, El Dorado, El Dorado, Kansas

AMR Clinical - Newton, Newton, Kansas

Lynn Health Science Institute - Oklahoma City, Oklahoma City, Oklahoma

India

Endolife Specialty Hospitals Pvt. Ltd., Guntur, Andhra Pradesh

Life Care Hospital and Research Centre, Bangalore, Karnataka

Government Medical College, Kozhikode, Kerala

Jothydevs Diabetes Research Centre, Trivandrum, Kerala

Nirmal Hospital Private Limited, Kolhāpur, Maharashtra

Topiwala National Medical College & BYL Nair Hospital, Mumbai, Maharashtra

Seth G. S. medical college and KEM hospital, Mumbai, Maharashtra

BSES Municipal General Hospital, Mumbai, Maharashtra

LMMF's Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra

Lady Hardinge Medical College and S.S.K. Hospital, New Delhi, National Capital Territory of Delhi

All India Institute of Medical Sciences, New Delhi, National Capital Territory of Delhi

Madras Diabetes Research Foundation (MDRF), Chennai, Tamil Nadu